Recombinant Human Anti-HBV Antibody (C9G9)

This product is a human monoclonal IgG kappa antibody targeting human hepatitis B surface antigen. Antibody C9G9 can effectively block the HBV replication in vitro, and therefore has a good ability to neutralize the hepatitis B virus, as prevention of HBV infection drugs.
Supplier Creative Biolabs
Product # HPAB-0002-WJ
Pricing Inquiry
Host Human
Target HBV
Species Reactivity Hepatitis B virus
Type Human IgG
Applications Neut
Feedback